MEGAN EILEEN MORRISON
Allopathic & Osteopathic Physicians|Dermatology|MOHS-Micrographic Surgery THOMPSONS STATION, TN NPI 1306159728
Browse related groups: Allopathic & Osteopathic Physicians|Dermatology|MOHS-Micrographic Surgery TN ABBVIE INC. All categories
General Payments — all program years on this page
$10,784.77
- Category: General Payments
- Program years: PY2018–2024
- Record count: 404
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $2,303.16 across 103 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $2,203.17 | 102 |
| Education | $99.99 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $427.59 | 20 |
| Lilly USA, LLC | $281.62 | 13 |
| Janssen Biotech, Inc. | $267.56 | 11 |
| GENZYME CORPORATION | $257.81 | 7 |
| Incyte Corporation | $146.24 | 7 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $145.07 | 8 |
| Amgen Inc. | $119.47 | 5 |
| REVANCE THERAPEUTICS, INC. | $111.24 | 6 |
| Regeneron Healthcare Solutions, Inc. | $75.28 | 3 |
| UCB, Inc. | $70.87 | 3 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $67.10 | 3 |
| LEO Pharma Inc. | $66.92 | 3 |
| PFIZER INC. | $58.35 | 3 |
| Dermavant Sciences, Inc. | $41.71 | 2 |
| Verrica Pharmaceuticals Inc. | $41.20 | 2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $37.85 | 2 |
| Genentech USA, Inc. | $27.20 | 2 |
| Fresenius Kabi USA, LLC | $23.95 | 1 |
| Galderma Laboratories, L.P. | $23.76 | 1 |
| Biofrontera Inc. | $12.37 | 1 |
By program year
Records — PY2024 (103)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.